Historical record - last NADAC publication: 2/19/2020
Product Information
RANITIDINE 300 MG CAPSULE is a generic product labeled by Ajanta Pharma USA Inc., priced at $0.5821 per EA under NDC 27241011010. Its NADAC has been published 103 times since Feb 27, 2019.
The High Outlier badge above means this manufacturer's average price in the Ranitidine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
300 mg/1
Manufacturer
Ajanta Pharma USA Inc.NDC
27241011010
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
2/19/2020
Active Ingredients
RANITIDINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209859On Market Since
9/27/2018
Pharmacological Classes
Price Statistics
The NADAC for RANITIDINE 300 MG CAPSULE has been published 103 times since Feb 27, 2019, and over the history we have for it it has declined 45.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5821 per EA |
|---|---|
| All-time high | $1.0649 (Mar 13, 2019) |
| All-time low | $0.5821 (Feb 19, 2020) |
| Median price | $0.5821 |
| Average price | $0.7203 |
| Largest weekly change | +45.8% (May 22, 2019) |
| Weeks tracked | 103 |
| Tracking since | Feb 27, 2019 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 66% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RANITIDINE 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for RANITIDINE 300 MG CAPSULE, manufactured by Ajanta Pharma USA Inc., is $0.5821 per EA (NDC 27241011010), effective Feb 10, 2021.
How has the price of RANITIDINE 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for RANITIDINE 300 MG CAPSULE has declined 45.3%. It has been tracked across 103 weekly CMS publications since Feb 27, 2019.
What are the highest and lowest recorded NADAC prices for RANITIDINE 300 MG CAPSULE?
Since Feb 27, 2019, the NADAC for RANITIDINE 300 MG CAPSULE has ranged from a low of $0.5821 (Feb 19, 2020) to a high of $1.0649 (Mar 13, 2019), with a median of $0.5821 per EA.
Are there cheaper alternatives to RANITIDINE 300 MG CAPSULE?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, RANITIDINE 300 MG TABLET, is $0.1968 per EA — about 66% below RANITIDINE 300 MG CAPSULE.
Who manufactures RANITIDINE 300 MG CAPSULE?
RANITIDINE 300 MG CAPSULE (NDC 27241011010) is labeled by Ajanta Pharma USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification